SHOX2 and laryngotracheoesophageal cleft: Later, the analysis of a combination of SHOX2 and PTEGR4 methylation levels in blood demonstrated significant discriminatory performance in distinguishing patients with LC from subjects without malignancy (AUC = from 0.86) [9].